MFJCX | RFUTX | MFJCX / RFUTX | |
Total Expense Ratio | 1.58 | 0.39 | 405% |
Annual Report Gross Expense Ratio | 1.93 | 0.39 | 495% |
Fund Existence | 9 years | 10 years | - |
Gain YTD | 13.329 | 17.234 | 77% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 250 | 400% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | N/A | 18.2B | - |
Annual Yield % from dividends | 1.36 | 1.02 | 133% |
Returns for 1 year | 11.13 | 16.36 | 68% |
Returns for 3 years | 39.39 | 52.49 | 75% |
Returns for 5 years | 50.34 | 51.37 | 98% |
Returns for 10 years | N/A | 127.05 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
MLPB | 25.53 | 0.06 | +0.23% |
UBS ETRACS Alerian MLPInfrs ETN SerB | |||
CCMG | 31.09 | 0.05 | +0.16% |
CCM Global Equity ETF | |||
SZOXF | 7.01 | N/A | N/A |
Deutsche Bank AG (London Branch) | |||
BIB | 56.55 | -0.01 | -0.01% |
ProShares Ultra Nasdaq Biotechnology | |||
MMAX | 26.07 | -0.01 | -0.04% |
iShares Large Cap Max Buffer Mar ETF |